Stay updated on Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision from v3.4.2 to v3.4.3 was applied. The study page content and layout appear unchanged.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedAdded explicit mention of Gastric cancer and a Resources section linking to the Genetic and Rare Diseases Information Center; these are informational updates that do not alter core study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision: v3.4.2 added and the funding notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check45 days agoChange DetectedA site-wide notice regarding a lapse in government funding was added to the page, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check52 days agoChange DetectedA glossary is now displayed to help users understand terms on the page. QC metadata has been updated to show Last Update Submitted that Met QC Criteria and the new revision label (v3.4.0), replacing the previous QC label (Last Update Submitted that met QC Criteria) and the older revision.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.